Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Daniel O'Day
Special Reports
The 10 highest-paid Big Pharma CEOs of 2024
While many familiar names appear on Fierce’s 2024 pharma CEO pay ladder, multiple executives have rubber banded across the rankings, and the top spot has gone to a dark horse contender.
Fraiser Kansteiner
,
Zoey Becker
,
Eric Sagonowsky
,
Angus Liu
,
Kevin Dunleavy
Jun 16, 2025 3:00am
Gilead bumps CEO Daniel O'Day's compensation package to $23.7M
Mar 28, 2025 10:47am
The top 10 best-paid CEOs in Big Pharma in 2023
Jun 17, 2024 3:00am
Gilead writes $2.4B off Trodelvy as CEO underscores focus
Apr 26, 2024 11:21am
Gilead CEO Daniel O'Day collects 5% pay raise to $22.6M
Mar 19, 2024 1:13pm
PhRMA taps Gilead CEO Dan O'Day as its new board chair
Feb 21, 2024 2:51pm
